Crescita Therapeutics Inc.
CRRTF
$0.31
-$0.04-10.71%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 117.82% | 57.05% | -26.55% | -36.50% | -303.07% |
| Total Depreciation and Amortization | 2.50% | -7.20% | -14.83% | -10.64% | -8.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -341.85% | -95.43% | -59.57% | -74.18% | 58.27% |
| Change in Net Operating Assets | -58.45% | -42.34% | 387.27% | 112.05% | 333.18% |
| Cash from Operations | 84.56% | 60.67% | 451.92% | 28.42% | 722.22% |
| Capital Expenditure | 24.86% | -34.85% | -1,505.20% | -1,458.31% | -4,338.36% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 21.54% | -27.37% | -1,446.89% | -1,400.00% | -1,619.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.93% | -6.81% | -7.67% | -8.09% | -7.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 24.24% | 42.97% | 39.49% | 18.58% | -26.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | 0.00% | -- | 0.00% |
| Cash from Financing | 9.95% | 20.31% | 17.21% | -8.40% | -16.95% |
| Foreign Exchange rate Adjustments | 378.57% | 65.93% | 369.09% | 396.12% | -361.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.97% | 33.55% | -30.48% | -111.22% | -120.78% |